Biogen Inc. Company Profile

Aggregated data from the web about Biogen Inc.

Company Name	Biogen Inc.
Website	https://www.biogen.com
Snippet	At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.
Type	Public
Founded	1978
Revenue	US$12.274 billion (2017)[1]
Website	biogen.com
Formerly	Biogen Idec Inc. (2003–2015)
Founders	Kenneth MurrayPhillip Allen SharpWalter GilbertHeinz Schaller Charles Weissmann
Industry	Biotechnology
Products	Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza
Traded as	NASDAQ: BIIB, NASDAQ-100 component, S&P 100 component, S&P 500 component
Key people	Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO)
Net income	US$2.539 billion (2017)[1]
Headquarters	Cambridge, Massachusetts, U.S.
Total assets	US$23.653 billion (2017)[1]
Total equity	US$12.613 billion (2017)[1]
Operating income	US$5.344 billion (2017)[1]
Number of employees	~7,300 (December 2017)[1]

Biogen Inc. is part of the United States company list

Biogen Inc. is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.